These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 22178066

  • 1. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, Østerud B, Mathiesen EB, Hansen JB.
    Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
    [Abstract] [Full Text] [Related]

  • 2. Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
    Sovershaev MA, Egorina EM, Bogdanov VY, Seredkina N, Fallon JT, Valkov AY, Østerud B, Hansen JB.
    Thromb Res; 2010 Oct; 126(4):306-10. PubMed ID: 20656331
    [Abstract] [Full Text] [Related]

  • 3. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
    Egorina EM, Sovershaev MA, Bogdanov VY, Sovershaev TA, Fallon JT, Seredkina N, Østerud B, Hansen JB.
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
    [Abstract] [Full Text] [Related]

  • 4. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A, Kotschy M, Jawien A.
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [Abstract] [Full Text] [Related]

  • 5. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
    Zawadzki C, Susen S, Richard F, Haulon S, Corseaux D, Jeanpierre E, Vincentelli A, Lucas C, Torpier G, Martin A, Van Belle E, Staels B, Jude B.
    Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206
    [Abstract] [Full Text] [Related]

  • 6. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K.
    J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
    [Abstract] [Full Text] [Related]

  • 7. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study.
    Krupinski J, Turu MM, Font MA, Catena E, Slevin M, Morchon S, Rubio F, Badimon L, Martínez-González J.
    Cerebrovasc Dis; 2008 Jun; 25(1-2):32-9. PubMed ID: 18033956
    [Abstract] [Full Text] [Related]

  • 8. Tissue factor pathway inhibitor expression in atherosclerosis.
    Drew AF, Davenport P, Apostolopoulos J, Tipping PG.
    Lab Invest; 1997 Oct; 77(4):291-8. PubMed ID: 9354763
    [Abstract] [Full Text] [Related]

  • 9. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis.
    Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Lüderitz B, Fallon JT, Fuster V, Badimon JJ.
    Circulation; 2004 Apr 27; 109(16):2001-8. PubMed ID: 15078795
    [Abstract] [Full Text] [Related]

  • 10. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology.
    Wahlgren CM, Zheng W, Shaalan W, Tang J, Bassiouny HS.
    Cerebrovasc Dis; 2009 Apr 27; 27(2):193-200. PubMed ID: 19136823
    [Abstract] [Full Text] [Related]

  • 11. Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients.
    Sardo MA, Campo S, Castaldo M, Bonaiuto A, Bitto A, Saitta C, Cristadoro S, Trimarchi G, Saitta A.
    J Hypertens; 2006 Apr 27; 24(4):731-6. PubMed ID: 16531802
    [Abstract] [Full Text] [Related]

  • 12. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar 27; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 13. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J, Soria C, Cornillet-Lefèbvre P, Nguyen P, Lenormand B, Mishal Z, Vannier JP, Vasse M.
    Br J Haematol; 2005 Nov 27; 131(3):356-65. PubMed ID: 16225656
    [Abstract] [Full Text] [Related]

  • 14. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
    Basavaraj MG, Gruber FX, Sovershaev M, Appelbom HI, Osterud B, Petersen LC, Hansen JB.
    Thromb Res; 2010 Nov 27; 126(5):418-25. PubMed ID: 20723970
    [Abstract] [Full Text] [Related]

  • 15. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression.
    Øvstebø R, Aass HC, Haug KB, Trøseid AM, Gopinathan U, Kierulf P, Berg JP, Brandtzaeg P, Henriksson CE.
    Innate Immun; 2012 Aug 27; 18(4):580-91. PubMed ID: 22180561
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor/TFPI and blood cells.
    Osterud B.
    Thromb Res; 2012 Mar 27; 129(3):274-8. PubMed ID: 22197177
    [Abstract] [Full Text] [Related]

  • 17. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R.
    Int Angiol; 2008 Aug 27; 27(4):296-301. PubMed ID: 18677291
    [Abstract] [Full Text] [Related]

  • 18. Relevance of tissue factor in cardiovascular disease.
    Jude B, Zawadzki C, Susen S, Corseaux D.
    Arch Mal Coeur Vaiss; 2005 Jun 27; 98(6):667-71. PubMed ID: 16007822
    [Abstract] [Full Text] [Related]

  • 19. Tissue factor in acute coronary syndromes.
    Ott I.
    Semin Vasc Med; 2003 May 27; 3(2):185-92. PubMed ID: 15199481
    [Abstract] [Full Text] [Related]

  • 20. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
    Caplice NM, Mueske CS, Kleppe LS, Simari RD.
    Circulation; 1998 Sep 15; 98(11):1051-7. PubMed ID: 9736590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.